Product Description
We are involved in offering tenofovir disproxil fumarate and lamivudine tablets, which have been made using the right combination of ingredients. It is considered as an antiviral medication which is profusely demanded for the treatment of HIV. The intake of this medicine helps in slowing the process of virus replication and providing relief to the suffering patients. Tenofovir disproxil fumarate and lamivudine tablets ought to be taken under the prescriptions of the healthcare experts who are authentic and have experience. The right dosage of the medicine is recommended to avoid severe side effects.
High-Quality HIV-1 TreatmentFormulated to meet international standards, these tablets combine two potent antiretroviral agents recommended for managing HIV-1 infection in adults and adolescents. Manufactured in WHO-GMP/ISO-certified facilities, the product delivers consistent efficacy and safety for worldwide export.
Trusted Manufacturing and PackagingProduced in compliance with global GMP and ISO norms, these tablets are presented in blister packs sealed within secondary cartons for assured integrity. Each batch meets stringent pharmaceutical assays, guaranteeing not less than 98% of each active ingredient. The secure packaging preserves tablet stability over the product's 36-month shelf life.
Convenient Dosage and StorageWith a straightforward oral administration route, patients need to take one tablet daily as prescribed by a healthcare provider. The packaging ensures easy dispensing and tracking, while clear storage instructions (below 30C, dry and away from light) extend the product's efficacy and safety up to its expiration date.
FAQ's of Tenofovir Disoproxil Fumarate and Lamivudine Tablets:
Q: How should Tenofovir Disoproxil Fumarate and Lamivudine Tablets be taken for optimal effectiveness?
A: These tablets should be taken orally, once daily, as directed by your healthcare provider. Consistent daily dosing is important for maintaining effective drug levels in the body and achieving optimal control of HIV-1 infection.
Q: What benefits does this combination tablet offer for HIV-1 treatment?
A: This medication combines two proven antiretrovirals, Tenofovir Disoproxil Fumarate and Lamivudine, providing effective suppression of HIV-1 replication. The once-daily dosing and dual action help simplify therapy and enhance patient adherence.
Q: When is this medication indicated and who can use it?
A: This product is indicated for adults and adolescents diagnosed with HIV-1 infection. It is a prescription-only medicine and should be used under medical supervision to ensure safety and effectiveness.
Q: Where is this medicine manufactured and how is quality ensured?
A: The tablets are manufactured in India at WHO-GMP/ISO-certified facilities, ensuring compliance with stringent international quality and safety standards. Each batch undergoes thorough quality control and meets export regulations.
Q: What is the recommended storage process for these tablets?
A: Store the tablets in a dry location below 30C and protected from light. Proper storage preserves drug potency and ensures the full 36-month shelf life from the date of manufacturing.
Q: Are there any contraindications or precautions for usage?
A: This medication should not be used by individuals with known hypersensitivity to Tenofovir Disoproxil Fumarate, Lamivudine, or any other component of the tablet. Always consult your healthcare provider about potential interactions and medical history before starting therapy.
Q: What makes this product suitable for international export?
A: This medicine meets pharmaceutical-grade standards, is WHO-GMP certified, and complies with international regulations, making it reliable and suitable for global distribution by exporters, suppliers, traders, and wholesalers.